Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1Other hematologic neoplasm 1CNS 1

Conditions

Spinal Cord Neoplasms 1Optic Nerve Glioma 1Medulloblastoma 1Familial ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Choroid Plexus Neoplasms 1Burkitt Lymphoma 1Astrocytoma 1

Interventions

Cyclophosphamide 59fludarabine phosphate 39Filgrastim 36Peripheral Blood Stem Cell Transplantation 34Cyclosporine 31Radiotherapy 30Busulfan 30Mycophenolic Acid 28Antilymphocyte Serum 27Whole-Body Irradiation 25Melphalan 22Etoposide 22Methylprednisolone 20Methotrexate 20Tacrolimus 16Cord Blood Stem Cell Transplantation 16Cytarabine 12Thiotepa 10Rituximab 8Vincristine 7Granulocyte Colony-Stimulating Factor 7sargramostim 6Carboplatin 6fludarabine 5aldesleukin 5Sirolimus 5Psychiatric Rehabilitation 5Prednisone 5Leucovorin 5Doxorubicin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Burkitt Lymphoma × CK0238273 × Sarcoma × Clear all
NCT00363272 2013-01-16

Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
CNSLymphoidSarcoma

Familial ependymoma, Astrocytoma, Burkitt Lymphoma, Medulloblastoma, Spinal Cord Neoplasms, Choroid Plexus Neoplasms, Optic Nerve Glioma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡